Amount raised
$133M
Round
Series B
Date raised
November 5, 2026
Founded
2022
CompanyT-Therapeutics
IndustryBiotechnology
LocationCambridge, United Kingdom
InvestorsBritish Business Bank, Advent Life Sciences
Websitet-therapeutics.com
Get new raises like this every week
Free weekly list of newly funded startups and their founders.
About T-Therapeutics
a biotechnology company developing next-generation T cell receptor (TCR) T cell engager (TCE) therapeutics for cancer and autoimmune diseases
- How much did T-Therapeutics raise?
- T-Therapeutics raised $133M in a Series B round on November 5, 2026. Investors include British Business Bank, Advent Life Sciences.
- Who founded T-Therapeutics?
- No founder is listed for T-Therapeutics yet.
- Where is T-Therapeutics based?
- T-Therapeutics is based in Cambridge, United Kingdom.